FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System

Terry Smith, Managing Director said " This designation by the FDA is a validation of our core belief at JointMedica — that our hip resurfacing device addresses an acute unmet need of relatively younger, active hip arthritis patients"

​

We would like to give special thanks to our friends at MCRA for assisting us with this process.

​

Click here for the full press release.